LMWH Infusion as Anticoagulation for Home HD

• Status: Unknown status
• Trial end date: 2018-05-01
• Target enrollment: 0
• Participant gender: All

Summary

There is a lack of data in the literature about the use of low-molecular weight heparin (LMWH) as anticoagulation for nocturnal home hemodialysis (NHHD). This study aims to evaluate the efficacy and safety of LMWH, administered by infusion method, as compared to unfractionated heparin as anticoagulation for NHHD treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alice Ho Miu Ling Nethersole Hospital
• Treatments: Calcium heparin; Dalteparin; Heparin; Heparin, Low-Molecular-Weight; Nadroparin

Criteria

Inclusion Criteria:

• Prevalent NHHD patients who have received >1 year dialysis with unfractionated heparin as anticoagulant

• Age >= 18

• Informed consent available

Exclusion Criteria:

• History of intolerance to LMWHs during HD

• Receiving warfarin or other oral anticoagulant

• Pregnant patients